Vashist, Y.; Aigner, K.; Dam, M.; Gailhofer, S.; Aigner, K.R.
Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment. Curr. Oncol. 2022, 29, 4868-4878.
https://doi.org/10.3390/curroncol29070386
AMA Style
Vashist Y, Aigner K, Dam M, Gailhofer S, Aigner KR.
Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment. Current Oncology. 2022; 29(7):4868-4878.
https://doi.org/10.3390/curroncol29070386
Chicago/Turabian Style
Vashist, Yogesh, Kornelia Aigner, Miriam Dam, Sabine Gailhofer, and Karl R. Aigner.
2022. "Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment" Current Oncology 29, no. 7: 4868-4878.
https://doi.org/10.3390/curroncol29070386
APA Style
Vashist, Y., Aigner, K., Dam, M., Gailhofer, S., & Aigner, K. R.
(2022). Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment. Current Oncology, 29(7), 4868-4878.
https://doi.org/10.3390/curroncol29070386